Study to Describe the Real-world Treatment Patterns and Associated Outcomes in Patients With HER2-positive Unresectable or Metastatic Breast Cancer
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Metastatic Breast Cancer
Interventions: OTHER: None (Observational study)
Sponsor: AstraZeneca
Collaborators: Parexel